Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Neurology
|
February 9, 2021
Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD
M Isabel Leite
Autoimmunity
|
April 13, 2010
Diagnostic use of autoantibodies in myasthenia gravis
M Isabel Leite, Patrick Waters, Angela Vincent
Neurology
|
December 31, 2015
Author's Response:
Mkael Symmonds, M Isabel Leite, Ursula G Schulz
Multiple Sclerosis and Related Disorders
|
May 24, 2023
A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)
M Isabel Leite, Zoya Panahloo, Niall Harrison, et al.
JAMA Neurology
|
January 16, 2024
MOG-IgA as a Potential Marker of Germinal Center Activity
Adam E Handel, Sarosh R Irani, M Isabel Leite
Journal of the Neurological Sciences
|
June 1, 2015
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease
Andrew Murchison, Joanna Kitley, M Isabel Leite, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 3, 2013
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
Joanna Kitley, M Isabel Leite, Liene Elsone, et al.
Journal of Neuroimmunology
|
January 29, 2019
NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia
Sharon A Savage, Sarosh R Irani, M Isabel Leite, et al.
Practical Neurology
|
May 16, 2015
Whippits, nitrous oxide and the dangers of legal highs
Alexander G Thompson, M Isabel Leite, Michael P Lunn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 4, 2015
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO
Joanna Kitley, Mark Woodhall, M Isabel Leite, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Neurology
|
February 9, 2021
Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD
M Isabel Leite
Autoimmunity
|
April 13, 2010
Diagnostic use of autoantibodies in myasthenia gravis
M Isabel Leite, Patrick Waters, Angela Vincent
Neurology
|
December 31, 2015
Author's Response:
Mkael Symmonds, M Isabel Leite, Ursula G Schulz
Multiple Sclerosis and Related Disorders
|
May 24, 2023
A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)
M Isabel Leite, Zoya Panahloo, Niall Harrison, et al.
JAMA Neurology
|
January 16, 2024
MOG-IgA as a Potential Marker of Germinal Center Activity
Adam E Handel, Sarosh R Irani, M Isabel Leite
Journal of the Neurological Sciences
|
June 1, 2015
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease
Andrew Murchison, Joanna Kitley, M Isabel Leite, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 3, 2013
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
Joanna Kitley, M Isabel Leite, Liene Elsone, et al.
Journal of Neuroimmunology
|
January 29, 2019
NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia
Sharon A Savage, Sarosh R Irani, M Isabel Leite, et al.
Practical Neurology
|
May 16, 2015
Whippits, nitrous oxide and the dangers of legal highs
Alexander G Thompson, M Isabel Leite, Michael P Lunn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 4, 2015
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO
Joanna Kitley, Mark Woodhall, M Isabel Leite, et al.
Page
of 8